Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan(University of Minnesota), Dana E. Rathkopf(Memorial Sloan Kettering Cancer Center), Eric J. Small(CancerCare Manitoba), Karim Fizazi(Université de Lille), Paul de Souza(St. George Hospital), Christopher J. Logothetis(The University of Texas MD Anderson Cancer Center), Josep M. Piulats(Institut Català d'Ornitologia), Paul N. Mainwaring(Australasia Paediatric Endocrine Group), Eric Winquist(Western University), Daniel J. George(Duke University), Fred Saad(Centre Hospitalier de l’Université de Montréal), Thian Kheoh(Janssen (United States)), Hendrik Van Poppel(Universitair Ziekenhuis Leuven), Peter F.A. Mulders(Radboud University Nijmegen), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Howard I. Scher(Memorial Sloan Kettering Cancer Center), Eleni Efstathiou(The University of Texas MD Anderson Cancer Center), Youn Park(Janssen (Belgium)), Evan Y. Yu(University of Washington), Thomas W. Flaig(University of Colorado Denver), Ethan Basch(UNC Lineberger Comprehensive Cancer Center), Matthew R. Smith(Massachusetts General Hospital), Arturo Molina(Janssen (United States)), Dirk Schrijvers(ZNA Middelheim Hospital), Som D. Mukherjee(Juravinski Cancer Centre), H. Suttmann, Allan J. Pantuck(University of California System), Mary-Ellen Taplin(Dana-Farber Brigham Cancer Center), Siobhan Ng(St John of God Subiaco Hospital), Winald R. Gerritsen(Radboud University Nijmegen), Celestia S. Higano(University of British Columbia), Thomas W. Griffin(Janssen (Belgium)), Joan Carles(Vall d'Hebron Hospital Universitari)
Cited by 2,789
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k